All Products
  • Antibodies
  • 试剂盒
  • 多肽
  • 探针
  • 蛋白
  • 生化试剂
  • 组织芯片
CH
cAMP/ cGMP/ Protein A/ β-Actin/ BSA/ Ddx4/ APOE/ TAU pT181/ TAU pT217/ Tau 1-441/ Aβ1-40/ Aβ1-42/ α-Syn/ GFAP/ IL/ CD/ 标记试剂盒/ GFP/ Flag/ 多肽合成服务/ /
抗体药类似物
Path：Home > Products > Antibodies > 抗体药类似物
Products
Products
Research Grade Garadacimab
All
  • Catalog： TD-HF664016
  • Clonality： mAb
  • Application： Research Grade Biosimilar
  • Synonyms： CSL312,CAS:2162134-62-3
  • Specification：
    1mg
  • Prices：
    ¥询价
Customized service consulting
Information
FAQ
Experimental program
Related Products
Bibliography

Research Grade Garadacimab

Catalog No. TD-HF664016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG4-lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target F12, HAF, Hageman factor, Beta-factor XIIa part 2, Coagulation factor XII
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P00748
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names CSL312,CAS:2162134-62-3
Background Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
Note For research use only. Not for use in clinical or therapeutic applications.